🇺🇸 FDA
Pipeline program

Qizhitongluo Capsule

QZTL2013

Approved small_molecule completed

Quick answer

Qizhitongluo Capsule for Ischemic Stroke is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Ischemic Stroke
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials